NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 127 filers reported holding NURIX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,707 | -81.5% | 1,235 | -76.5% | 0.00% | – |
| Q2 2023 | $52,587 | +382.3% | 5,264 | +328.7% | 0.00% | – |
| Q1 2023 | $10,904 | +10.2% | 1,228 | +36.3% | 0.00% | – |
| Q4 2022 | $9,892 | -17.6% | 901 | -2.2% | 0.00% | – |
| Q3 2022 | $12,000 | -36.8% | 921 | -41.1% | 0.00% | – |
| Q2 2022 | $19,000 | -81.0% | 1,563 | -78.2% | 0.00% | – |
| Q1 2022 | $100,000 | -43.8% | 7,174 | +16.1% | 0.00% | – |
| Q4 2021 | $178,000 | – | 6,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |